BNP Paribas Financial Markets’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Buy |
|
|||||
|
2025
Q1 | $3.64K | Sell |
|
|||||
|
2024
Q4 | $6.06K | Sell |
|
|||||
|
2024
Q3 | $32.8K | Buy |
|
|||||
|
2024
Q2 | $16.6K | Buy |
|
|||||
|
2024
Q1 | $4.25K | Sell |
|
|||||
|
2023
Q4 | $3.06K | Sell |
|
|||||
|
2023
Q3 | $4.36K | Sell |
|
|||||
|
2023
Q2 | $79.6K | Sell |
|
|||||
|
2023
Q1 | $734K | Buy |
|
|||||
|
2022
Q4 | $785K | Sell |
|
|||||
|
2022
Q3 | $1.05M | Buy |
|
|||||
|
2022
Q2 | $95.8K | Buy |
|
|||||
|
2022
Q1 | $80.7K | Sell |
|
|||||
|
2021
Q4 | $396K | Buy |
|
|||||
|
2021
Q3 | $376K | Buy |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2021
Q1 | $213K | Sell |
|
|||||
|
2020
Q4 | $511K | Sell |
|
|||||
|
2020
Q3 | $2.92M | Buy |
|
|||||
|
2020
Q2 | $469K | Sell |
|
|||||
|
2020
Q1 | $215K | Buy |
|
|||||
|
2019
Q4 | $35.5K | Sell |
|
|||||
|
2019
Q3 | $28.9K | Buy |
|
|||||
|
2019
Q2 | $28.3K | Sell |
|
|||||
|
2019
Q1 | $67.9K | Buy |
|
|||||
|
2018
Q4 | $124 | Sell |
|
|||||
|
2018
Q3 | $17K | Hold |
|
|||||
|
2018
Q2 | $12K | Sell |
|
|||||
|
2018
Q1 | $84.2K | Buy |
|
|||||
|
2017
Q4 | $72.4K | Buy |
|
|||||
|
2017
Q3 | $44.3K | Sell |
|
|||||
|
2017
Q2 | $58.9K | Buy |
|
|||||
|
2017
Q1 | $3.01K | Sell |
|
|||||
|
2016
Q4 | $8.18K | Sell |
|
|||||
|
2016
Q3 | $42.7K | Buy |
|
|||||
|
2016
Q2 | $23.8K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $106K | Buy |
|
|||||
|
2015
Q3 | $85.8K | Buy |
|
|||||
|
2015
Q2 | $48.7K | Buy |
|
|||||
|
2015
Q1 | $11.7K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $35.2K | Buy |
|